CH
PPBT

CVI Holdings’s Purple Biotech PPBT Stock Holding History

CVI Holdings’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-989
Closed -$605K – 74
2020
Q1 		$605K Buy
+989
New +$1.21M 2.12% 12

Other funds holding PPBT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
BFC
Bedel Financial Consulting Indianapolis, Indiana $1.06B AUM 38.33% 1-Year Est. Return

CVI Holdings's PPBT Position: Q2 2020 in Review

CVI Holdings sold out of Purple Biotech (PPBT) in Q2 2020, closing a stake of 989 shares — an estimated $605K sold.

CVI Holdings first reported a position in PPBT in Q1 2020 and held it in 1 quarter. The position peaked at $605K in Q1 2020. 29 funds tracked by Wall St. Rank hold PPBT as of Q2 2020.

  • CVI Holdings reported no remaining Purple Biotech position as of Q2 2020 after selling out during the quarter.
  • CVI Holdings sold 989 Purple Biotech shares in Q2 2020, an estimated $605K.
  • CVI Holdings first reported a position in Purple Biotech in Q1 2020 and held it in 1 quarter.
  • CVI Holdings's Purple Biotech position peaked at $605K in Q1 2020.
  • 29 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2020.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.